Council

The Council consists of the members of the EC and one delegate of each Adhering Organisation.

According to the statutes, updated on August 28, 2021, the voting rights are allotted according to the following rules:

  • members of the EC: 1 vote
  • countries with up to 99 members: 2 votes
  • countries with 100-199 members: 3 votes
  • countries with 200-399 members: 4 votes
  • countries with 400-599 members: 5 votes
  • countries with 600-899 members: 6 votes
  • countries with 900-1199 members: 7 votes
  • countries with 1200-1599 members: 8 votes
  • countries with 1600-1999 members: 9 votes
  • countries with 2000-2499 members: 10 votes
  • countries with 2500-2999 members: 11 votes
  • countries with more than 3000 members: 12 votes

As for countries with more than one Adhering Organisation, votes will be proportionally distributed among them, taking into account their respective memberships. The resulting number will be rounded off to the closest digit. In the distribution process, each NAO will receive at least one vote.

Università Magna Græcia di Catanzaro, Italy
Division of Medicinal Chemistry of the Italian Chemical Society (Divisione di Chimica Farmaceutica - Società Chimica Italiana, DCF-SCI)

University of Ljubljana, Slovenia
Section for Medicinal Chemistry of the Slovenian Pharmaceutical Society

Ankara University, Turkey
EFMC Executive Committee

Novartis, Switzerland
EFMC Executive Committee

Institute of Physiologically Active Compounds, Russia
The D.I. Mendeleev Russian Chemical Society, Medicinal Chemistry Section

JOHNSON & JOHNSON PHARMACEUTICAL R&D, Spain
Spanish Society of Medicinal Chemistry (Sociedad Española de Química Terapéutica)

GIO Therapeutics, Switzerland
EFMC Executive Committee

University of Copenhagen, Denmark
The Danish Society for Medicinal Chemistry and Chemical Biology

Universität Kiel, Germany
German Pharmaceutical Society, Section of Pharmaceutical/Medicinal Chemistry

Universidad San Pablo Ceu, Spain
EFMC Executive Committee

Université de Lille / Institut Pasteur de Lille, France
French Medicinal Chemistry Society (Société de Chimie Thérapeutique, SCT)

Maastricht University, The Netherlands
Division Medicinal Chemistry & Chemical Biology, Royal Netherlands Chemical Society (KNCV-MCCB)

Charles University, Czech Republic
Section of Synthetic Drug of the Czech Pharmaceutical Society

Vilnius University, Lithuania
Lithuanian Chemical Society

University of Liège, Belgium
Medicinal Chemistry Division of the Société Royale de Chimie (SRC)

University of Lisbon, Portugal
Division of Medicinal Chemistry of the Portuguese Chemical Society

AstraZeneca, United Kingdom
Society for Medicines Research

Helmholtz Institute for Pharmaceutical Research Saarland, Germany

Division of Medicinal Chemistry of the German Chemical Society (GDCh)

Karolinska Institutet, Sweden
Swedish Pharmaceutical Society

Hungarian Academy of Sciences, Hungary
Organic and Medicinal Chemistry Division (OMCD) of the Hungarian Chemical Society (HCS)

University of Mostar, Bosnia-Herzegovina
Organization Pharmaceutical Research Institute

Selvita Ltd., Croatia
Croatian Chemical Society, Section of Medicinal/Pharmaceutical Chemistry

Fenerbahçe University, Turkey
Turkish Association of Medicinal and Pharmaceutical Chemistry

University of Vienna, Austria
Austrian Chemical Society, Medicinal Chemistry Section

The Weizmann Institute of Science, Israel
The Medicinal Chemistry Section of the Israel Chemical Society

Medical University of Lublin, Poland
Polish Society of Medicinal Chemistry

University of Athens, Greece
Hellenic Society of Medicinal Chemistry

CIC bioGUNE, Spain
Spanish Chemical Biology Group of the Royal Spanish Society of Chemistry (RSEQ)

Novartis, Switzerland
EFMC Executive Committee

University of Bonn, Germany
EFMC Executive Committee

UNIVERSITY COLLEGE DUBLIN (IRELAND), Ireland
Medicinal and Biological Chemistry Division of the Institute of Chemistry of Ireland

University of Salerno, Italy
EFMC Executive Committee

University of Belgrade – Faculty of Chemistry, Serbia
Serbian Chemical Society, Division of Medicinal Chemistry

UNIVERSITY OF HELSINKI, Finland
Finnish Pharmaceutical Society

F. Hoffmann-La Roche Ltd, Switzerland
Division for Medicinal Chemistry & Chemical Biology (DMCCB)

Pharmaron UK, United Kingdom
The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC)

Ghent University, Belgium
Medicinal and Bioorganic Chemistry Division of Royal Flemish Chemical Society (KVCV)

Novalix, France
EFMC Executive Committee

CNRS, France
Chemical Biology Division of the French Chemical Society (SCF-ChemBio)